 |
|
 UPCOMING EVENTS |
|
|
| |
|
To be announced |
|
|
|
| PAST EVENTS |
|
| |
 |
XV International Symposium on Atherosclerosis
Hynes Convention Center, Boston, MA; June 14-18, 2009 |
|
| |
|
American Diabetes Association 69th Scientific Sessions
Morial Convention Center, New Orleans, LA; June 5-9, 2009 |
|
|
| |
|
BayBio 2009 Conference
South San Francisco Conference Center, South San Francisco, CA; April 16, 2009 |
|
| |
|
Piper Jaffray 20th Annual Health Care Conference
The New York Palace, New York, NY; December 2-3, 2008 |
|
| |
|
Windhover’s Therapeutic Area Partnerships
Loews Hotel, Philadelphia, PA; November 3-5, 2008 |
|
| |
|
2nd World Congress on Controversies to Consensus in Diabetes, Obesity, and Hypertension (CODHy)
Catalonia Palace of Congresses, Barcelona, Spain; October 30-November 2, 2008 |
|
| |
|
BIO Investor Forum
Palace Hotel, San Francisco, CA; October 29-31, 2008 |
|
| |
|
BIO International Convention
San Diego Convention Center,
San Diego, CA; June 17-20, 2008 |
|
| |
|
Canaccord Adams Diabetes &
Obesity Conference
Hotel Nikko, San Francisco, CA; June 6, 2008 |
|
|
|
|
2009 NEWS |
| |
| METABOLEX CLOSES $8.6 MILLION FINANCING ROUND |
|
| November 5, 2009 |
|
| Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, today announced it had closed an additional $8.6 million in financing. |
| |
|
More > |
| |
| METABOLEX ANNOUNCES POSITIVE PHASE 1 CLINICAL TRIAL RESULTS OF MBX-2982 |
|
| October 13, 2009 |
|
| Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982. |
| |
|
More > |
| |
| LOCAL SMALL BUSINESS HONORED AT FORMAL STATE RECOGNITION CELEBRATION |
|
| May 26, 2009 |
|
| A crowd of 500 business leaders, legislators, corporate partners, and small business dignitaries applauded as Dr. Harold Van Wart was honored as “California Small Business of the Year” for District #18. |
| |
|
More > |
| |
| METABOLEX ANNOUNCES ELECTION OF KURT VON EMSTER TO BOARD OF DIRECTORS |
|
| April 22, 2009 |
|
| Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new therapeutics for the treatment of diabetes and related metabolic disorders, announced that Kurt von Emster has been elected to its Board of Directors. |
| |
|
More > |
| |
|
|
|
